WEEKLY UPDATE
June 16
New Users Please Click to Register
Renew or Upgrade your Existing  Account
UPDATE EMAIL
CHECK STATUS
CHECK PASSWORD

DISCLOSURE
BOOKMARK-HDCN
VBOOTHS
ABOUT OUR SITE
SYMPOSIA
FREE ZONE INDEX
ABSTRACTS
BY DATE
BY TOPIC
SEARCH HDCN
JOURNALS
SOCIETIES, LINKS
CLINICAL TRIALS
HYPERTENSION
DIALYSIS-CRF
CLIN NEPHROL
FREE ZONE
KEY ZONE
SEARCH

VBOOTHS :  Google :  PubMed  :   Scholar  :   K/DOQI :  UpToDate :  MDRD GFR
Slides/audio/handouts:    RPA-2008(s/a/h)  :  ASDIN-2008(s/a/h)  :  RRI-2008(s/a/h)  :  ASN-2007(a)  :  ADC-2007(a)  :  RPA-2007(s/a)  :  RRI-2007(s/a/h)  : 
Search HDCN:  FreeTalks   (key):   Articles :  Abstracts :  Audiofiles :  SlideTalks :  LegacyTalks  

Hildebrandt  

Kaskel  

  The Genetics of FSGS. Flash slide/audio
(ASN Clinical Nephrology Conference, November, 2007)
Hildebrandt: What are the most common point mutations that cause FSGS and childhood nephrotic syndrome. How and when do they present? To what extent do they respond to treatment? Are any of them steroid responsive? Are they associated with recurrence post-transplantation? Where can one turn for gene analysis when an inherited mutation is suspected in a child with nephrotic syndrome? What are the characteristics of PLCE1 mutations (phospholipase C epsilon), and what should the approach to therapy of these patients be? Kaskel: What are predictors of outcome in FSGS? What are the general treatment approaches? How should steroids be used? Does cyclophosphamide or chlorambucil have a role? What do randomized trials show in terms of cyclosporine? What is the experience with MMF? With rapamycin? Pulse dexamethasone? What is the design of the ongoing NIH/NIDDK Study and when will we have results? When is plamapheresis indicated? What do preliminary results with rituximab show?
(more...)


ASDIN  

  ASDIN Annual Meeting. February, 2008. Part Three. Flash slide/audio -- Free to ASDIN members

Proximal radial anastomosis
Klaus Konner, M.D.

Drug Anaphylaxis - Immediate Hypersensitivity Reactions (IHR) to Radiocontrast Media (RCM)
Kenneth Abreo, M.D.

Role of CO2 Angiography in Dialysis Access Interventions
Timothy A. Pflederer, M.D.

Local Delivery Systems
Prabir Roy-Chaudhury MBBS, PhD, FRCP

Arteriovenous Fistula Thrombosis Is there a standard method?
Arif Asif, M.D.

AVF vs AVG thrombectomy
Aris Q. Urbanes M.D.

(more...)


Hypertension, Cardiovascular
Anthropometrics predicts metabolic syndrome.
Screening for type 2 DM (guideline)
Aldo in resistant hypertension
Radial artery for CABG
Poor medication adherence and HTN
Intensive glucose lowering - ACCORD
Intensive glucose lowering - ADVANCE
Aliskiren plus losartan in type 2 DM nephropathy
CKD, ESRD
How much vitamin D do we need?
Calcium supplementation lowers fracture risk
Should DVT patients be checked for thrombophilia?
Osteonecrosis of the jaw with bisphosphonates
25-D levels and myocardial infarction
Adynamic bone disease (review)
Clinical Nephrology
Urinary NGAL to detect AKI




ASN Renal Week 2007
now in MP3
AUDIOFILE LIST (Renal Week 2007)

2007 Renal Week PGE Course:

PGE: REACTIVE OXYGEN SPECIES (Part 1 of 2)

Recent Advances in Superoxide Detection
Raman Kalyanaraman, PhD

Nitric Oxide and Nitrosothiol Detection: The Basics
Neil Hogg, PhD

The Vascular NADPH Oxidase and Inflammation: Crossroads at the Adventitia?
Patrick J. Pagano, PhD

NADPH Oxidase Structure, Regulation, and Binding Partners
Anthony W. Segal, MB, PhD

Role of SOD in ALS: Lessons from Transgenic Mice
Joseph Beckman, PhD

CuZnSOD versus MnSOD: Biological Role and Pathophysiology
Ting-Ting Huang, PhD

Hemoxygenase: An Intracellular Antioxidant
Mahin D. Maines, PhD

Antioxidant Mechanisms of Vitamin C
Balz Frei, PhD

Antioxidant Mechanisms of Gamma- and Alpha-Tocopherols
Kenneth Hensley, PhD

Peroxiredoxins
Aron B. Fisher, MD




    Hit reload / refresh
Login stopped working? Bouncing email logins suspended.
Slide/audio problem when lectures played with legacy options using Windows Media or Real Player.
HDCN_RSS  Click on RSS for details of each news story.
Updated: July 03, 2008 (J03)
J03 NEJM: Scanning the blood for circulating tumor cells using DNA technology helps guide treatment of metastatic disease.
J03 VA/NIH study of dialysis dose in acute kidney failure published in NEJM
J03 Statins spur glial progenitor cells to develop into oligodendrocytes.
J03 Pfizer will no longer work directly with for-profit CME companies.
J03 Novel antibiotic ceftobirole kills even the most resistant Staph. aureus.
J03 CMS releases 2007 ESRD Clinical Performance Measures report (.pdf)
J03 Secondary analysis of CHOIR data suggests that high EPO doses, rather than high Hb per se, associated with mortality.
J03 FDA panel recommends that all new diabetes drugs be screened for cardiovascular risk.
J02 New orally active, broad-spectrum angiogenesis inhibitor may be useful against many cancers.
J02 Secret of herpesvirus latency discovered in strands of microRNA.
J01 Caffeine intake increases rate at which muscle replenishes glycogen stores after exercise.
J01 Indocyanine green plus laser light kills even resistant bacteria; application to wound infections.
J01 Medicare proposes changes for dialysis reimbursement.
J01 More on the physician Medicare payment cut battle in the Congress.
J01 FDA may start focusing more on software reliability in medical devices.
J01 Bills pending in Congress would remove Supreme Court shield for medical device manufacturers.
J01 Doxycycline-inhibitable protease activity increased in SHR rats; this also may explain various aspects of metabolic syndrome.
J30 Doctors get temporary reprieve on Medicare cuts.
J30 Cancer cure strategy in mice to be tested in humans: transfusion of allogeneic cancer-killing leukocytes.
J30 Volcanoes turn out to be an important source of mercury pollution.
General Advances Emphasis
archive
Lipid abnormalities and cardiovascular risk in renal disease
Ritz and Wanner review the effects of CKD on lipids, the evidence that lipid control may slow progression, and suggest treatment regimens in this population; from the June issue of the J Am Soc Nephrol (JASN) (more...)

Role of remission clinics in the longitudinal treatment of CKD
What is a remission clinic for CKD patients, and what are the results in terms of progression when patients are aggressively monitored and treated in this way? Ruggenenti and colleagues tells us, in the June issue of the J Am Soc Nephrol (JASN) (more...)

Staging of chronic kidney disease: time for a course correction
Bauer et al tell us why the NKF KDOQI staging system is seriously flawed; from the May issue of the J Am Soc Nephrol (JASN) (more...)

Idiopathic membranous nephropathy: diagnosis and treatment
Fervenza and colleagues review the latest approach to idiopathic membranous nephropathy; from the May issue of the Clinical J Am Soc Nephrol (CJASN) (more...)

High-molecular weight iron dextran: a wolf in sheep's clothing?
Rodgers et al describe patient allergic reactions in patients switched from low to higher MW dextrans by the pharmacy in order to save costs. from the May issue of the J Am Soc Nephrol (JASN) (more...)

Nephrogenic systemic fibrosis: early recognition and treatment
Knopp and Cowper review the very early signs of this disorder, and discuss criteria for diagnosis as well as etiology. from the April issue of Seminars in Dialysis. (more...)

Glucose in the dialysate: Historical perspective and possible implications?
Sharma and Rosner discuss this. Should we add glucose at all? If so, how much is too much, and how much is enough? from the April issue of Hemodialysis International. (more...)

Atherosclerotic renal artery stenosis: overtreated but underrated?
Textor reviews the latest in terms of diagnosis and treatment; this test; from the April issue of the J Am Soc Nephrol (JASN) (more...)

Trends in organ donation and transplantation in the United States, 1997-2006
Port and his colleagues document the trends in organ transplantation and transplantation up through 2006; in the April 2008 issue of the Am J Transplant. (more...)

Revisiting the dialysate sodium prescription as a tool for better blood pressure and interdialytic weight gain management in hemodialysis patients.
Santos and Peixoto review the current recommendations for optimizing dialysate sodium level in dialysis patients; from the March issue of the Clinical J Am Soc Nephrol (CJASN) (more...)

The utility of the transtubular potassium gradient in the evaluation of hyperkalemia
Choi and Ziyadeh review how the TTKG can be used to distinguish etiology of hyperkalemia, and discuss the pitfalls and shortcomings of this test; from the March issue of the J Am Soc Nephrol (JASN) (more...)

Beta-blockade in chronic dialysis patients
Furgeson and Chonchol review the data of benefit, and also point out the potential risks of using them in CKD; in the Jan/Feb issue of Seminars in Dialysis. (more...)

450+
  SUMMARIES of Recent Slide/Audio Symposia in reverse chronological order

The Genetics of FSGS (Hildebrandt and Kaskel)
Primary Care Issues in Nephrology: Peripheral Vascular Disease: Assessments and Approaches to Care (Froehlich); Rheumatology for Nephrologists (Kay).
Achieving Control: Optimizing the Management of CKD-Anemia (Nissenson, Fishbane, Germain, and Provenzano)
Mycophenolate in Lupus and Non-Glomerular Renal Diseases (Shaw and Appel)
  ASDIN Annual Meeting 2008
  RPA Annual Meeting 2008
  Advances in CKD 2008 (RRI 10th Annual International Dialysis Symposium
Management of Hyperphosphatemia in Patients with ESRD: A New Direction for Treatment in 2008 (Qunibi and Nolan)
Aldosterone: New Insights in Kidney Health and Disease (Calhoun and Rosenberg)
Pre-ESRD and Mineral Metabolism (Martin and Moe)
New Insights into Common Problems After Kidney Transplantation (Kasiske and Weisinger)
Challenges and Opportunities in the Treatment of Hyperuricemia and Gout (Terkeltaub, Rich, Feig)
New Treatments for Diabetes Mellitus: Implications for Clinicians (Nelson and Bakris)
The Aging Kidney (Fliser and Aronoff)
Phosphate Binders in CKD: An Update on Treatment Outcomes and Future Directions (London, Langman, Ketteler)
Challenges in Volume Management. Optimizing Care in Patients with Heart Failure and Renal Dysfunction (Burnett, Fowler, Gheorghiade)
Cardiovascular Disease in End Stage Renal Disease Patients (Henrich)
Contrast Media and CKD: What You Should Know About Contrast-Induced Nephropathy and Nephrogenic Systemic Fibrosis (Persson, Knopp, Perazella)
New Developments in Anemia Management in Chronic Kidney Disease (Roy, Besarab, Amerling, Berns)
The Cystic Diseases (Bennett)
Navigating the Erythropoietin Stimulating Agent Landscape in CKD-Related Anemia (Berns, Provenzano, Szczech)
Critical Care Nephrology (Murray)
FREE
Chronic Kidney Disease - Mineral Bone Disorder (Arruda, Snavely)
Electrolyte/Acid-Base Emergencies in the ICU (Palmer)
Nocturnal and Frequent Dialysis: Are These the Preferred Therapies for Patients with Cardiovascular Disease?
FREE
Updating Practices in an Evolving IV Iron and Anemia Environment: Practical Solutions. A New Anemia Treatment Paradigm in Favor of the Patient (Easom, Juergensen, Amerling)
Sudden Death in Hemodialysis Patients: Epidemiology
Diabetes and Non-insulin Management in CKD
Obesity and Outcomes in Dialysis Patients
Is Obesity a Risk Factor for the Development And Progression of Chronic Kidney Disease?
FREE
Standards: The Basis of Care to Manage the Patient with Complications of Chronic Kidney Disease Leading to Cardiovascular Disease (Burrows-Hudson, Headley, Campoy)
FREE
Achieving and Maintaining a Phosphate Balance in the Patient With CKD (Mathers)
Cocaine and Chronic Kidney Injury
Proton Pump Inhibitors and the Kidney: Critical Review
Characteristics of the Long-Term Peritoneal Dialysis Patient
Prospects and Challenges for a Staphylococcal Vaccine
Alternatives to Vancomycin in the Treatment of Gram-Positive Cocci
Overview of Catheter Lock Solutions
Are ACE inhibitors and ARBs Essential to Renoprotection? Debate.
Early Anemia Management: Incorporating New Evidence Into Appropriate Treatment Strategies for Chronic Kidney Disease
3rd Annual Scientific Meeting of the ASDIN. April, 2007.
Improving Efficiency in the Nephrologist's Office. RPA Annual Meeting (2007)
RRI Ninth International Conference on Dialysis, January, 2007. Part Four
Bone and Mineral Metabolism in CKD: Medical Crossfire
RRI Ninth International Conference on Dialysis, January, 2007. Part Three
Fluid Dysregulation: Disturbances and Management
RRI Ninth International Conference on Dialysis, January, 2007. Part Two
Inflammation in CKD: Biomarkers, Morbidity and Therapy
Managing CMV Infections in Transplantation
RRI Ninth International Conference on Dialysis, January, 2007. Part One
Disorders of Sodium Metabolism: Case Presentations
The CKD that Follows Renal Transplantation: How to Best Manage these Patients?
Transplant Biopsy
The New KDOQI Guidelines for Anemia; Debate: Should an Upper Hgb Limit be Set and What Should it Be?
Calcimimetics: Monotherapy for Secondary Hyperparathyroidism?
Lupus Nephritis: Defining and Treating Renal Flares
Secondary Hypertension, including Chronic Kidney Disease
New, Tri-Partite Approach to Anemia
Magnesium Balance: Hypomagnesemia and Hypermagnesemia
Pathogenesis and Management of Cardiovascular Disease (CVD) in Chronic Kidney Disease
Transplantation: Medical and Immunosuppressive Management
  Using Technology to Improve the Quality of Care (target audience: technicians)
more...











 
Site Description:
Hypertension, Dialysis, and Clinical Nephrology provides up-to-date, selected information on renal disorders and their treatment (hemodialysis, peritoneal dialysis), and about hypertension, dialysis, and clinical nephrology topics.
Hypertension, Dialysis, and Clinical Nephrology is a place for physicians and nurses who treat patients with kidney or renal disease. Here physicians and nurses can find answers to frequently asked hypertension, dialysis, and nephrology questions (FAQ), pointers to recent review articles, and summaries of hot new hypertension, dialysis, and nephrology papers, abstracts, and meeting presentations. Also, information about medical products, devices, services, and drugs pertaining to hypertension, dialysis, and clinical nephrology are provided, as is a list of links to relevant hypertension / dialysis / transplantation organizations, medical provider networks, and databases. Much of the information presented is collected from a distinguished editorial board composed of specialists in the field of kidney or renal disease.

Warning-Disclaimer:
The information at this server is provided with the understanding that the publisher, authors, and advisors are not rendering medical or professional services. Medicine is a rapidly changing area, and efforts have been made to provide information that is medically correct at the time of publication. However, there may be mistakes, both typographical and in content. The material provided should be used only as a general guide and not the ultimate source of information. The material should not be used to form the basis of personal or professional decisions. The authors, advisors, and publisher shall have neither liability not responsibility to any person or entity with respect to any loss or damage alleged to be caused directly or indirectly by the information presented in this journal/server.

Copyright statement:
Copyright - 1995 - 2008 by Medtext, Inc. All rights reserved. No part of the material on this journal/server may be reproduced in any form or by any electronic or mechanical means, including information storage and retrieval systems, without permission in writing from the publisher, except by a reviewer who may quote brief passages in a review.

Published by Medtext, Inc., Burr Ridge, IL, 630-325-3276
E-mail to: editor (at sign) hdcn.com

96 97 98 99